Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma

Cutaneous squamous cell carcinoma (CSCC) accounts for approximately 20% of all keratinocytic tumors. In most cases, the diagnosis and treatments are made on small, low-risk lesions. However, in about 5% of cases, CSCC may present as either locally advanced or metastatic (i.e. with locoregional lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutros, Andrea, Cecchi, Federica, Tanda, Enrica Teresa, Croce, Elena, Gili, Riccardo, Arecco, Luca, Spagnolo, Francesco, Queirolo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427439/
https://www.ncbi.nlm.nih.gov/pubmed/34513710
http://dx.doi.org/10.3389/fonc.2021.733917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427439/
https://www.ncbi.nlm.nih.gov/pubmed/34513710
http://dx.doi.org/10.3389/fonc.2021.733917

Ejemplares similares